Comprehensive prioritisation scheme for active pharmaceutical ingredients in Denmark
Key Points
A comprehensive prioritization scheme identifies high-risk active pharmaceutical ingredients in Denmark, addressing environmental risks.
This analysis focuses on 2574 approved APIs in Denmark, pointing to the need for targeted monitoring efforts.
The study employs a prioritization framework to assess potential adverse effects on the environment from released APIs.
Findings may enable more efficient environmental monitoring initiatives for pharmaceuticals in Denmark.
Abstract
Active pharmaceutical ingredients (APIs) can cause severe adverse effects if released into the environment. In response to the 2574 APIs approved in Denmark and costly environmental monitoring initiatives, a prioritisation...